Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder
G Stiefel, FMC Besag - Drug safety, 2010 - Springer
Attention-deficit hyperactivity disorder (ADHD) is a very common condition in children and
often extends into the adult years. Drugs such as methylphenidate, amphetamines and …
often extends into the adult years. Drugs such as methylphenidate, amphetamines and …
Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update
GAH Awudu, FMC Besag - Drug safety, 2014 - Springer
Several million children and a growing number of adults are currently being treated for
attention-deficit hyperactivity disorder (ADHD) worldwide. Concerns have been expressed …
attention-deficit hyperactivity disorder (ADHD) worldwide. Concerns have been expressed …
Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder
J Martinez-Raga, C Knecht, N Szerman, MI Martinez - CNS drugs, 2013 - Springer
Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder
characterized by persistent symptoms of inattention, hyperactivity and/or impulsivity. The …
characterized by persistent symptoms of inattention, hyperactivity and/or impulsivity. The …
Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine
R Arcieri, EAP Germinario, M Bonati… - Journal of Child and …, 2012 - liebertpub.com
Objective: The purpose of this study was to assess the cardiovascular effects of drugs used
for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents treated in …
for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents treated in …
[HTML][HTML] Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of …
L Hennissen, MJ Bakker, T Banaschewski, S Carucci… - CNS drugs, 2017 - Springer
Background Many children and adolescents with attention deficit/hyperactivity disorder
(ADHD) are treated with stimulant and non-stimulant medication. ADHD medication may be …
(ADHD) are treated with stimulant and non-stimulant medication. ADHD medication may be …
Short-term cardiovascular effects of methylphenidate and adderall
RL Findling, EJ Short, MJ Manos - Journal of the American Academy of …, 2001 - Elsevier
OBJECTIVE: The primary purpose of this study was to examine the cardiovascular effects of
Adderall®(ADL) in a clinic-based group of youths with attention-deficit/hyperactivity disorder …
Adderall®(ADL) in a clinic-based group of youths with attention-deficit/hyperactivity disorder …
Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder
DJ Safer - Journal of child and Adolescent Psychopharmacology, 1992 - liebertpub.com
The pertinent literature was reviewed on cardiovascular changes induced by
psychostimulant medication treatment of hyperactive children. An assessment of 15 …
psychostimulant medication treatment of hyperactive children. An assessment of 15 …
[HTML][HTML] The effect of methylphenidate and atomoxetine on heart rate and systolic blood pressure in young people and adults with attention-deficit hyperactivity …
Objectives: This meta-analysis aims to study the effects of atomoxetine and methylphenidate
on heart rate (HR), systolic blood pressure (SBP), and a number of adverse cardiac events …
on heart rate (HR), systolic blood pressure (SBP), and a number of adverse cardiac events …
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD
AG Winterstein, T Gerhard, J Shuster, A Saidi - Pediatrics, 2009 - publications.aap.org
OBJECTIVES: Safety concerns about central nervous system stimulants for the treatment of
attention-deficit/hyperactivity disorder (ADHD) include adverse cardiac effects. This study …
attention-deficit/hyperactivity disorder (ADHD) include adverse cardiac effects. This study …
Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function
B Vitiello - Child and adolescent psychiatric clinics of North …, 2008 - Elsevier
The effects of stimulant medications and atomoxetine on physical growth and on
cardiovascular function are reviewed in light of the most recent data, with attention to clinical …
cardiovascular function are reviewed in light of the most recent data, with attention to clinical …
相关搜索
- attention deficit hyperactivity disorder
- cardiovascular effects hyperactivity disorder
- attention deficit cardiovascular effects
- atomoxetine in the treatment hyperactivity disorder
- atomoxetine in the treatment cardiovascular effects
- attention deficit atomoxetine in the treatment
- cardiovascular effects trials of methylphenidate
- attention deficit young children
- cardiovascular measures methylphenidate and atomoxetine
- cardiac safety treatment of adhd
- atomoxetine treatment young children
- cardiovascular effects meta analysis
- attention deficit methylphenidate and atomoxetine
- attention deficit cardiovascular risks
- attention deficit cardiovascular measures